Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias

Hooman Rashidi, Xiangdong Xu, Huan You Wang, Nelofar Q. Shafi, Karuna Rameshkumar, Karen Messer, Brian R. Smith, Michal G. Rose

Research output: Contribution to journal › Article

5 Citations (Scopus)

Abstract

The diagnostic utility of flow cytometry in the evaluation of cytopenias and in the differential diagnosis of low -grade versus high-grade myelodysplastic syndrome (MDS) is not widely appreciated. In this report, we measured granulocyte CD10/control fluorescence ratio in 29 patients with MDS & chronic myelomonocytic leukemia (CMML) using peripheral blood (PB) flow cytometry (FC). We found a lower ratio in high-grade MDS and CMML (mean ratio of 2.2 ± 0.7) vs. low-grade MDS (3.65 ± 0.9) and 16 cytopenic controls without MDS (3.67 ± 0.65; p<0.001). The sensitivity and specificity of CD10 ratio <3 for the group that included the high risk MDS and CMML patients were 87.5% and 100%, respectively. Our data suggests that FC of PB may be helpful in the work-up of patients with cytopenias and in the differential diagnosis of low-grade vs. high-grade MDS.

Original languageEnglish (US)
Pages (from-to)224-230
Number of pages7
JournalInternational Journal of Clinical and Experimental Pathology
Volume5
Issue number3
StatePublished - May 23 2012

Fingerprint

Myelodysplastic Syndromes
Flow Cytometry
Leukemia, Myelomonocytic, Chronic
Differential Diagnosis
Granulocytes
Fluorescence
Sensitivity and Specificity

Keywords

  • Bone marrow
  • CD10
  • Flow cytometry
  • High-grade MDS
  • Low-grade MDS
  • Myelodysplastic syndromes
  • Peripheral blood

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias. / Rashidi, Hooman; Xu, Xiangdong; Wang, Huan You; Shafi, Nelofar Q.; Rameshkumar, Karuna; Messer, Karen; Smith, Brian R.; Rose, Michal G.

In: International Journal of Clinical and Experimental Pathology, Vol. 5, No. 3, 23.05.2012, p. 224-230.

Research output: Contribution to journal › Article

Rashidi, H, Xu, X, Wang, HY, Shafi, NQ, Rameshkumar, K, Messer, K, Smith, BR & Rose, MG 2012, 'Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias', International Journal of Clinical and Experimental Pathology, vol. 5, no. 3, pp. 224-230.
Rashidi H, Xu X, Wang HY, Shafi NQ, Rameshkumar K, Messer K et al. Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias. International Journal of Clinical and Experimental Pathology. 2012 May 23;5(3):224-230.
Rashidi, Hooman ; Xu, Xiangdong ; Wang, Huan You ; Shafi, Nelofar Q. ; Rameshkumar, Karuna ; Messer, Karen ; Smith, Brian R. ; Rose, Michal G. / Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias. In: International Journal of Clinical and Experimental Pathology. 2012 ; Vol. 5, No. 3. pp. 224-230.
@article{bffd335138fc4e938ff8b94429af1d43,
title = "Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias",
abstract = "The diagnostic utility of flow cytometry in the evaluation of cytopenias and in the differential diagnosis of low -grade versus high-grade myelodysplastic syndrome (MDS) is not widely appreciated. In this report, we measured granulocyte CD10/control fluorescence ratio in 29 patients with MDS & chronic myelomonocytic leukemia (CMML) using peripheral blood (PB) flow cytometry (FC). We found a lower ratio in high-grade MDS and CMML (mean ratio of 2.2 ± 0.7) vs. low-grade MDS (3.65 ± 0.9) and 16 cytopenic controls without MDS (3.67 ± 0.65; p<0.001). The sensitivity and specificity of CD10 ratio <3 for the group that included the high risk MDS and CMML patients were 87.5{\%} and 100{\%}, respectively. Our data suggests that FC of PB may be helpful in the work-up of patients with cytopenias and in the differential diagnosis of low-grade vs. high-grade MDS.",
keywords = "Bone marrow, CD10, Flow cytometry, High-grade MDS, Low-grade MDS, Myelodysplastic syndromes, Peripheral blood",
author = "Hooman Rashidi and Xiangdong Xu and Wang, {Huan You} and Shafi, {Nelofar Q.} and Karuna Rameshkumar and Karen Messer and Smith, {Brian R.} and Rose, {Michal G.}",
year = "2012",
month = "5",
day = "23",
language = "English (US)",
volume = "5",
pages = "224--230",
journal = "International Journal of Clinical and Experimental Pathology",
issn = "1936-2625",
publisher = "e-Century Publishing Corporation",
number = "3",

}

TY - JOUR

T1 - Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias

AU - Rashidi, Hooman

AU - Xu, Xiangdong

AU - Wang, Huan You

AU - Shafi, Nelofar Q.

AU - Rameshkumar, Karuna

AU - Messer, Karen

AU - Smith, Brian R.

AU - Rose, Michal G.

PY - 2012/5/23

Y1 - 2012/5/23

N2 - The diagnostic utility of flow cytometry in the evaluation of cytopenias and in the differential diagnosis of low -grade versus high-grade myelodysplastic syndrome (MDS) is not widely appreciated. In this report, we measured granulocyte CD10/control fluorescence ratio in 29 patients with MDS & chronic myelomonocytic leukemia (CMML) using peripheral blood (PB) flow cytometry (FC). We found a lower ratio in high-grade MDS and CMML (mean ratio of 2.2 ± 0.7) vs. low-grade MDS (3.65 ± 0.9) and 16 cytopenic controls without MDS (3.67 ± 0.65; p<0.001). The sensitivity and specificity of CD10 ratio <3 for the group that included the high risk MDS and CMML patients were 87.5% and 100%, respectively. Our data suggests that FC of PB may be helpful in the work-up of patients with cytopenias and in the differential diagnosis of low-grade vs. high-grade MDS.

AB - The diagnostic utility of flow cytometry in the evaluation of cytopenias and in the differential diagnosis of low -grade versus high-grade myelodysplastic syndrome (MDS) is not widely appreciated. In this report, we measured granulocyte CD10/control fluorescence ratio in 29 patients with MDS & chronic myelomonocytic leukemia (CMML) using peripheral blood (PB) flow cytometry (FC). We found a lower ratio in high-grade MDS and CMML (mean ratio of 2.2 ± 0.7) vs. low-grade MDS (3.65 ± 0.9) and 16 cytopenic controls without MDS (3.67 ± 0.65; p<0.001). The sensitivity and specificity of CD10 ratio <3 for the group that included the high risk MDS and CMML patients were 87.5% and 100%, respectively. Our data suggests that FC of PB may be helpful in the work-up of patients with cytopenias and in the differential diagnosis of low-grade vs. high-grade MDS.

KW - Bone marrow

KW - CD10

KW - Flow cytometry

KW - High-grade MDS

KW - Low-grade MDS

KW - Myelodysplastic syndromes

KW - Peripheral blood

UR - http://www.scopus.com/inward/record.url?scp=84861204904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861204904&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 224

EP - 230

JO - International Journal of Clinical and Experimental Pathology

JF - International Journal of Clinical and Experimental Pathology

SN - 1936-2625

IS - 3

ER -

Access to Document